March 13, 2013 - Volume 27 - Issue 5 - Contributor Index

Author:
Gabuzda, Dana
Author:
Galli, Massimo

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment

Lapadula, Giuseppe; Cozzi-Lepri, Alessandro; Marchetti, Giulia; More

AIDS . 27(5):769-779, March 13, 2013.

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

Rallon, Norma I.; Lopez-Fernandez, Luis A.; Garcia, Maria Isabel; More

AIDS . 27(5):687-696, March 13, 2013.

Once-daily darunavir/ritonavir and abacavir/lamivudine versus tenofovir/emtricitabine for treatment-naïve patients with a baseline viral load of more than 100 000 copies/ml

Nishijima, Takeshi; Komatsu, Hirokazu; Teruya, Katsuji; More

AIDS . 27(5):839-842, March 13, 2013.

Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men

Sander, Petra M.; Cole, Stephen R.; Stall, Ronald D.; More

AIDS . 27(5):815-823, March 13, 2013.

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

Colbers, Angela P.H.; Hawkins, David A.; Gingelmaier, Andrea; More

AIDS . 27(5):739-748, March 13, 2013.

Author:
Gillor, Daniel

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

Colbers, Angela P.H.; Hawkins, David A.; Gingelmaier, Andrea; More

AIDS . 27(5):739-748, March 13, 2013.

Author:
Gori, Andrea

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment

Lapadula, Giuseppe; Cozzi-Lepri, Alessandro; Marchetti, Giulia; More

AIDS . 27(5):769-779, March 13, 2013.

Author:
Greig, Caitlin